Structure/function relationships of mitochondrial protein carrier (SLC25A20) for carnitine/acylcarnitine: A review.
Level 5 - mechanism / opinion, no new human data
Narrative review of structural, in vitro, and in silico mechanistic research
PubMed 41875964 · doi:10.1016/j.bbamem.2026.184524
What was done
The authors reviewed three decades of in vitro, in silico, and homology modeling research regarding the structural features and transport mechanisms of the mitochondrial carnitine/acylcarnitine carrier (CAC, encoded by SLC25A20), utilizing comparative structural data from the ADP/ATP carrier.
What was found
The abstract reports no quantitative values or statistical metrics. It summarizes qualitative structural models supporting a single-binding centered-gated pore transport mechanism common to mitochondrial carriers, alongside evidence for transient CAC dimerization and supramolecular complex formation with substrate-channeling properties.
Why it matters
Understanding the molecular transport mechanisms and structural dynamics of SLC25A20 helps clarify the pathophysiology of inherited carnitine cycle disorders and provides a framework for targeted therapeutic design.
Limits
The review relies primarily on in silico homology modeling and in vitro assays rather than an experimentally resolved crystal structure of CAC. No clinical trials or patient-level quantitative outcome data are included.
Cited by
- supports Carnitine and acetyl-L-carnitine are required in the mitochondria for fatty acid oxidation.